Oncology Institute Inc.
TOI | NASDAQ
$5.13
-$1.26 (-19.72%)
At close: Aug 03, 2026, 04:00 PM ET
-19.72%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $512.91M
1D Range
4.87 5.15
52W Range
2.32 7.05
Valuation (TTM)
PE -18.32
PB -20.59
EV/EBITDA -26.77
Valuation (NTM)
Forward PE N/A
Forward PEG 0.24
Price Target $8.67
Cash Flow
FCF Yield -0.6%
SBC Adj. FCF Yield -1.2%
SBC Impact -87.9%
Margins
Gross Margin 15.4%
Operating Margin -4.4%
FCF Margin -0.6%
Growth (CAGR)
Revenue 3Y | 5Y 26.1% |
24.7%
Dil EPS 3Y | 5Y 43.7% |
-6.8%
FCF 3Y | 5Y 104.2% |
42.9%
Returns
ROA -20.4%
ROE 209.8%
ROIC -28.8%
Financial Health
Net Cash
$16.49M
Current Ratio 1.36
Interest Coverage -3.42
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physicia...
Sector Healthcare
Industry Medical - Care Facilities
Employees 641
IPO Date Jun 4, 2020
Website theoncologyinstitute.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$9.00
Upside
+75.44%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TOI